Ergomed develops in orphan drug space with PSR Group acquisition

(8:41)

Stephen Stamp, CFO of Ergomed (ERGO) at Shares Investor Evenings

(28:35)

PharmInvent acquisition 'consolidates Ergomed's position in Europe

(3:40)

Ergomed plc - Equity Development Investor Forum, January 2017

(21:25)

Ergomed expanding via earnings-enhancing acquisitions

(7:13)

An interview with the management of Ergomed PLC

(23:21)

Ergomed PLC Webinar September 2017

(18:6)

Ergomed highlight 'year of strong delivery' both financially and strategically

(9:32)

Michael Demurjian - CEO, Aspargo Labs - Improving Patient Experience With Novel Formulations \u0026 Tech

(44:12)

Webinar: Pharmacovigilance Advanced Learning - Aggregate Reports Guidance

(43:59)

Webinar: Pharmacovigilance Agreements Guidance

(43:27)

Northern Business Leaders - Richard Harpin

(18:34)

Clinical Research 2.0? All you need to know about the planned ICH GCP revision

(58:1econd)

How to Reverse Narcolepsy: A Doctor's Remarkable Journey

(48:13)

Is now a good time to invest in AIM? – Richard Power, Octopus AIM Inheritance Tax Service

(14:41)

Reimagining pharmaceutical innovation | Thomas Pogge at TEDxCanberra

(18:10)

Ergomed in robust shape as it continues to perform 'above expectations'

(9:13)

Ergomed team discuss new project focused on virus outbreak and 'transformational 2019'

(13:37)

BIO-Europe Spring® 2017: Ergomed's evolution and risk-sharing business model in practice

(8:16)

Ergomed signs joint development deal with Sweden's Dilaforette

(7:8)

Ergomed Company Presentation June 2023

(5:6)

Ergomed eyeing up co-development deals, services contracts and acquisitions

(8:2)

Ergomed PLC (LON:ERGO) Presenting at the Proactive One2One virtual forum

(33:30)

Ergomed CEO says acquisition strategy should demand higher share price

(10:3)

Ergomed Webinar - September 2016

(34:40)

Ergomed (ERGO) - Richard Barfield, CFO

(26:15)

Ergomed plc (ERGO) - 29 July 2021

(58:40)